The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Novel analysis of 3-y results from the pivotal EPCORE NHL-1 study: Outcomes in patients (pts) with relapsed/refractory large B-cell lymphoma (R/R LBCL) and complete response (CR) at 2 y with epcoritamab (epcor) monotherapy.
 
Yasmin Karimi
Consulting or Advisory Role - Abbvie; ADC Therapeutics; AstraZeneca; Genmab; Merck; Roche/Genentech
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Genmab (Inst); Loxo/Lilly (Inst); Merck (Inst); Roche/Genentech (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
Julie Vose
Honoraria - Abbvie; Acerta Pharma/AstraZeneca; Adaptive Biotechnologies; Genmab; Ono Pharmaceutical
Consulting or Advisory Role - Foresight Diagnostics; Novartis
Research Funding - Acerta Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Epizyme; Genmab; Kite, a Gilead company (Inst); Loxo; Novartis (Inst); Seagen (Inst)
 
Michael Clausen
Consulting or Advisory Role - Abbvie; AstraZeneca; Genmab; Janssen; Roche
Travel, Accommodations, Expenses - AstraZeneca; Genmab; Janssen; Pfizer; Roche
 
David Cunningham
Stock and Other Ownership Interests - OVIBIO
Consulting or Advisory Role - OVIBIO
Research Funding - 4SC (Inst); Bayer (Inst); Clovis Oncology (Inst); Leap Oncology (Inst); Lilly (Inst); Roche (Inst)
 
Umar Farooq
Honoraria - Kite, a Gilead Company
Consulting or Advisory Role - MorphoSys
 
Tatyana Feldman
Stock and Other Ownership Interests - Genomic Testing Cooperative; OM Pharmaceutical Industries
Honoraria - ADC Therapeutics; AstraZeneca; Bristol Myers Squibb; Epizyme; Genmab; Pharmacyclics; SeaGen; Takeda
Consulting or Advisory Role - ADC Therapeutics; AstraZeneca; Bristol-Meyers Squibb; Epizyme; Genmab; Pharmacyclics; Seagen
Speakers' Bureau - Genmab; Seagen; Takeda
Research Funding - ADC Therapeutics (Inst); Alexion Pharmaceuticals (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Daiichi (Inst); Genmab; Kymera (Inst); Merck (Inst); Portola Pharmaceuticals (Inst); Seagen (Inst); Tessa Therapeutics (Inst); Trillium Therapeutics (Inst)
 
Hervé Ghesquieres
Honoraria - Abbvie; Gilead Sciences; Roche
Consulting or Advisory Role - Gilead Sciences; Roche
Travel, Accommodations, Expenses - Abbvie; Pierre Fabre
 
Wojciech Jurczak
Consulting or Advisory Role - Abbvie/Genentech; BeiGene; Lilly; Takeda
Research Funding - Abbvie/Genentech; AstraZeneca; BeiGene; Janssen-Cilag; Lilly; Roche; Takeda
 
Kim Linton
Honoraria - Karger Publishers; Roche
Consulting or Advisory Role - Abbvie; BeiGene; Bristol-Myers Squibb; Genmab; Roche
Speakers' Bureau - Genmab; Limbic Digital Media; Roche
Research Funding - BeiGene; Bristol-Myers Squibb; Genmab; Kite/Gilead; Nurix; Roche; Step Pharma
Expert Testimony - Abbvie; Nurix
Travel, Accommodations, Expenses - Abbvie; Genmab; Roche
 
Tycel Phillips
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; ADC Therapeutics; AstraZeneca; Bayer; BeiGene; BMS GmbH & Co. KG; Epizyme; Genentech; Genmab; Gilead Sciences; Incyte; Janssen; Kite/Gilead; Lilly; Merck; Pharmacyclics
Research Funding - Abbvie; Genentech
Other Relationship - Leukemia and Lymphoma Society
 
Won Kim
Research Funding - BeiGene; BeiGene; Boryung; Sanofi
 
Pegah Jafarinasabian
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
Travel, Accommodations, Expenses - Abbvie
 
Milan Geybels
Employment - Genmab; Novo Nordisk
Stock and Other Ownership Interests - Genmab; Novo Nordisk
 
David Soong
Employment - Genmab
Stock and Other Ownership Interests - Genmab
Research Funding - Genmab
Travel, Accommodations, Expenses - Genmab
 
Barbara Månsson
Employment - Genmab
 
Christian Eskelund
Employment - Genmab
 
Mohammad Atiya
Employment - Genmab
Stock and Other Ownership Interests - Genmab
 
Martin Hutchings
Consulting or Advisory Role - Abbvie; AstraZeneca; Genmab; Johnson & Johnson/Janssen; Roche; Takeda
Research Funding - Abbvie (Inst); Arvinas (Inst); AstraZeneca (Inst); Celgene (Inst); Genmab (Inst); Johnson & Johnson/Janssen (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Takeda (Inst)
 
Catherine Thieblemont
Honoraria - Abbvie; Bristol-Myers Squibb; Novartis; Roche
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Novartis; Roche
Travel, Accommodations, Expenses - Abbvie; Bristol-Myers Squibb; Novartis; Roche
 
Chan Cheah
Honoraria - Abbvie; AstraZeneca; BeiGene; Bristol-Myers Squibb; Crispr Therapeutics; Dizal Pharma; Genmab; Gilead Sciences; Janssen; Lilly; Menarini; Regeneron; Roche; SOBI
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Bristol-Myers Squibb; Crispr Therapeutics; Dizal Pharma; Genmab; Gilead Sciences; Janssen; Lilly; Menarini; Regeneron; Roche; SOBI
Speakers' Bureau - Abbvie; AstraZeneca; BeiGene; Genmab; Janssen; MSD; Roche
Research Funding - Abbvie; Bristol-Myers Squibb; Lilly; MSD; Roche
Travel, Accommodations, Expenses - BeiGene; Lilly